Saccharomyces cerevisiae infections and antifungal susceptibility studies by colorimetric and broth macrodilution methods
Abstract
Saccharomyces cerevisiae was isolated in large numbers from operative specimens from two patients with perforated bowel and peritonitis and from the blood of another patient treated with extracorporeal membrane oxygenation. Susceptibility studies were performed on these three isolates and another 29 isolates that colonized or caused infection in a total of 19 patients seen over the last decade. All isolates had low minimum inhibitory concentration (MIC) values for amphotericin B (MIC90 of < or = 0.02 microgram/ml) and flucytosine (MIC90 of 0.2 microgram/ml), and a broader range of MIC values for itraconazole (MIC90 of 0.8 microgram/ml) and fluconazole (MIC90 of 4 micrograms/ml). A colorimetric method using Alamar blue reagent showed good concordance with the standard broth macrodilution method for amphotericin B, flucytosine, and fluconazole, but less good concordance for itraconazole. Serious infections with S. cerevisiae probably should be treated with amphotericin B, with or without the addition of flucytosine.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Repeated observations have shown that S. cerevisiae can resist some antifungal drugs.
“the resistance of S. cerevisiae to certain antifungal agents has been also repeatedly observed.2,26,36,38”
Cites
Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B. C., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P. J., Friedman, D. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261301 · Cited by 1,168 · see citing works
Winston, D. J., Chandrasekar, P. H., Lazarus, H. M., Goodman, J. L., Silber, J. L., Horowitz, H. W., Shadduck, R. K., Rosenfeld, C. S., Ho, W. G., Islam, M. Z., et al. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-7-199304010-00003 · Cited by 373 · see citing works
Sangeorzan, J. A., Bradley, S. F., He, X., Zarins, L. T., Ridenour, G. L., Tiballi, R. N., & Kauffman, C. A. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90300-x · Cited by 322 · see citing works
Self-citationNew Spectrum of Fungal Infections in Patients with Cancer
Anaissie, E. J., Bodey, G. P., Kantarjian, H., Ro, J. Y., Vartivarian, S. E., Hopfer, R. L., Hoy, J., & Rolston, K. V. I. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.3.369 · Cited by 255 · see citing works
Pfaller, M. A., & Barry, A. L. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.8.1992-1996.1994 · Cited by 160 · see citing works
Invasive infection with Saccharomyces cerevisiae: report of three cases and review
Aucott, J. N., Fayen, J., Grossnicklas, H., Morrissey, A., Lederman, M. M., & Salata, R. A. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.3.406 · Cited by 137 · see citing works
The Prevalence of Yeasts in Clinical Specimens from Cancer Patients
Kiehn, T. E., Edwards, F. F., & Armstrong, D. (1980) · American Journal of Clinical Pathology · doi:10.1093/ajcp/73.4.518 · Cited by 118 · see citing works
Vaginitis due to Saccharomyces cerevisiae: epidemiology, clinical aspects and therapy
Sobel, J. D., Vazquez, J., Lynch, M., Meriwether, C., & Zervos, M. J. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/16.1.93 · Cited by 117 · see citing works
McCusker, J. H., Clemons, K. V., Stevens, D. A., & Davis, R. W. (1994) · Infection and Immunity · doi:10.1128/iai.62.12.5447-5455.1994 · Cited by 116 · see citing works
Comparative Pathogenesis of Clinical and Nonclinical Isolates of Saccharomyces cerevisiae
Clemons, K. V., McCusker, J. H., Davis, R. W., & Stevens, D. A. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.4.859 · Cited by 113 · see citing works
Saccharomyces cerevisiae pneumonia in a patient with acquired immune deficiency syndrome
Tawfik, O. W., Papasian, C. J., Dixon, A., & Potter, L. (1989) · Journal of Clinical Microbiology · doi:10.1128/jcm.27.7.1689-1691.1989 · Cited by 90 · see citing works
Use of a colorimetric system for yeast susceptibility testing
Tiballi, R. N., He, X., Zarins, L. T., Revankar, S. G., & Kauffman, C. A. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.4.915-917.1995 · Cited by 89 · see citing works
Self-citationMackenzie, D. W. R. (1962) · Medical Mycology · doi:10.1080/00362176285190051 · Cited by 77 · see citing works
Saccharomyces cerevisiaeinfections in man
Eng, R. H. K., Drehmel, R., Smith, S. M. R., & Goldstein, E. J. C. (1984) · Medical Mycology · doi:10.1080/00362178485380651 · Cited by 73 · see citing works
Stenderup, A., & Pedersen, G. T. (1962) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/j.1699-0463.1962.tb05088.x · Cited by 70 · see citing works
Pfaller, M. A., Vũ, Q. D., Lancaster, M., Espinel‐Ingroff, A., Fothergill, A. W., Grant, C., McGinnis, M. R., Pasarell, L., Rinaldi, M. G., & Steele‐Moore, L. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.7.1625-1628.1994 · Cited by 65 · see citing works
Saccharomyces cerevisiae fungemia: Case report and review of the literature
Cimolai, N., Gill, M. J., & Church, D. L. (1987) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(87)90158-1 · Cited by 60 · see citing works
Saccharomyces cerevisiae septicemia.
Eschete, M. L., & West, B. C. (1980) · PubMed · Cited by 53 · see citing works
Fungemia with Saccharomycetaceae: Report of four Cases and Review of the Literature
Nielsen, H., Stenderup, J., & Bruun, B. (1990) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549009027100 · Cited by 46 · see citing works
Stein, P. D., Folkens, A. T., & Hruska, K. A. (1970) · CHEST Journal · doi:10.1378/chest.58.2.173 · Cited by 38 · see citing works
Postoperative Peritonitis Caused by Saccharomyces cerevisiae
Dougherty, S. H. (1982) · Archives of Surgery · doi:10.1001/archsurg.1982.01380260114019 · Cited by 37 · see citing works
Saccharomyces fungemia in a patient with AIDS
Sethi, N., & Mandell, W. (1989) · Springer eBooks · doi:10.1007/978-1-4613-0807-2_40 · Cited by 36 · see citing works
Wilson, J., Jones, B. M., & Kinghorn, G. R. (1988) · Sexually Transmitted Diseases · doi:10.1097/00007435-198801000-00008 · Cited by 20 · see citing works
Tiballi, R. N., Zarins, L. T., He, X., & Kauffman, C. A. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.10.2612-2615.1995 · Cited by 18 · see citing works
Self-citationSaccharomyces cerevisiae septicemia
Eschete, M. L. (1980) · Archives of Internal Medicine · doi:10.1001/archinte.140.11.1539 · Cited by 10 · see citing works
Postoperative Peritonitis Due to Saccharomyces Cerivisiae—Treated with Ketoconazole
Canafax, D. M., Mann, H. J., & Dougherty, S. H. (1982) · Annals of Pharmacotherapy · doi:10.1177/106002808201600911 · Cited by 8 · see citing works
Septic arthritis due to saccharomyces species in a patient with chronic rheumatoid arthritis.
Feld, R. D., Fornasier, V., Bombardier, C., & Hastings, D. E. (1982) · PubMed · Cited by 7 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Emerging opportunistic yeast infections
Miceli, M. H., Díaz, J. A., & Lee, S. A. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70218-8 · Cited by 811 · see citing works
Arendrup, M. C., Boekhout, T., Akova, M., Meis, J. F. G. M., Cornely, O. A., & Lortholary, O. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12360 · Cited by 533 · see citing works
Invasive Saccharomyces Infection: A Comprehensive Review
Enache-Angoulvant, A., & Hennequin, C. (2005) · Clinical Infectious Diseases · doi:10.1086/497832 · Cited by 369 · see citing works
“We did not include asymptomatic patients with only 1 organism isolated from the peritoneal cavity after digestive perforation or surgery, or from urine, oral swab, stool, or vaginal swab specimens, because such patients were more likely to have colonization rather than true infection [20–22].”
BackgroundRapid Identification of <i>Candida</i> Species with Species-Specific DNA Probes
Elie, C. M., Lott, T. J., Reiss, E., & Morrison, C. J. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.11.3260-3265.1998 · Cited by 159 · see citing works
“cerevisiae are innately fluconazole resistant (21, 24, 31), clinical treatment decisions would most likely not be negatively impacted by the inability to discriminate C.”
BackgroundFungemia with Saccharomyces cerevisiae after treatment with Saccharomyces boulardii
Bassetti, S., Frei, R., & Zimmerli, W. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00133-8 · Cited by 103 · see citing works
Zhi-Jun, Y., Sriranganathan, N., Vaught, T., Arastu‐Kapur, S., & Ahmed, S. A. (1997) · Journal of Immunological Methods · doi:10.1016/s0022-1759(97)00171-3 · Cited by 99 · see citing works
Emergence of Saccharomyces cerevisiae as a human pathogen
Murphy, A., & Kavanagh, K. (1999) · Enzyme and Microbial Technology · doi:10.1016/s0141-0229(99)00086-1 · Cited by 98 · see citing works
“cerevisiae-induced disease [43] as is prolonged therapy [9].”
BackgroundSalonen, J. H., Richardson, M. D., Gallacher, K., Issakainen, J., Helenius, H. Y. M., Lehtonen, O. ‐., & NIKOSKELAINEN, J. (2000) · Journal of Hospital Infection · doi:10.1053/jhin.1999.0718 · Cited by 62 · see citing works
Cabral, M. E., Figueroa, L. I. C., & Fariña, J. I. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2012.09.006 · Cited by 54 · see citing works
In vitro susceptibility testing and DNA typing of Saccharomyces cerevisiae clinical isolates
Zerva, L., Hollis, R. J., & Pfaller, M. A. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.12.3031-3034.1996 · Cited by 54 · see citing works
“(17) demonstrated decreased susceptibility to fluconazole among clinical isolates of S.”
BackgroundResultInfluentialSwinne, D., Watelle, M., der Flaes, M. V., & NOLARD, N. (2004) · Mycoses · doi:10.1111/j.1439-0507.2004.00971.x · Cited by 52 · see citing works
Graf, C. E., & Gavazzi, G. (2006) · Journal of Infection · doi:10.1016/j.jinf.2006.01.019 · Cited by 40 · see citing works
Williams, J. S., Mufti, G. J., Powell, S. N., Salisbury, J. R., & Higgins, E. M. (2007) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2007.02375.x · Cited by 22 · see citing works
Saccharomyces cerevisiae: an Emerging and Model Pathogenic Fungus
McCusker, J. H. (2014) · ASM Press eBooks · doi:10.1128/9781555815776.ch18 · Cited by 21 · see citing works
Epidemiology of Saccharomyces fungemia: A systematic review
Vinayagamoorthy, K., Pentapati, K. C., & Prakash, H. (2023) · Medical Mycology · doi:10.1093/mmy/myad014 · Cited by 20 · see citing works
In vitroactivity of five antifungal agents against clinical isolates ofSaccharomyces cerevisiae
Barchiesi, F., Arzeni, D., Compagnucci, P., Francesco, L. F. D., Giacometti, A., & Scalise, G. (1998) · Medical Mycology · doi:10.1080/02681219880000701 · Cited by 19 · see citing works
Molecular epidemiology of Saccharomyces cerevisiae in an immunocompromised host unit
Clemons, K. V., Salonen, J. H., Issakainen, J., NIKOSKELAINEN, J., McCullough, M. J., Jorge, J., & Stevens, D. A. (2010) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.06.010 · Cited by 14 · see citing works
“Furthermore, this organism has been shown to be relatively resistant to azoles (Salonen et al., 2000; Tiballi et al., 1995; Zerva et al., 1996).”
BackgroundResultInfluentialSaccharomyces: A Friend or Foe in ICU (A Case Report with Solution)
Taneja, A., Gupta, P., & Singh, Y. (2019) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-23239 · Cited by 12 · see citing works
Lawrence, C. L., Okoh, O. A., Vishwapathi, V., McKenna, S. T., Critchley, M. E., & Smith, R. B. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104070 · Cited by 11 · see citing works
Saccharomyces cerevisiae oesophagitis in a patient with oesophageal carcinoma
Kliemann, D. A., Antonello, V. S., Severo, L. C., & Pasqualotto, A. C. (2011) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.1630 · Cited by 7 · see citing works
Almanza, L., Debien, B., Fontaine, B., & Brinquin, L. (1998) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/s0750-7658(98)80061-0 · Cited by 3 · see citing works
Saccharomyces cerevisiae fungemia in inflammatory bowel disease
Barman, P., Pande, R., Sengupta, S., & Bhalla, V. (2017) · Tropical Gastroenterology · doi:10.7869/tg.393 · Cited by 3 · see citing works
Infection urinaire à Saccharomyces cerevisiae : levure émergente ?
Elkhihal, B., Elhalimi, M., Ghfir, B., Mostachi, A., Lyagoubi, M., & Aoufi, S. (2015) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2015.09.004 · Cited by 2 · see citing works
ESCMID/ECMM Joint Clinical Guideline for the Diagnosis and Management of Rare Invasive Yeast
Arendrup, M. C., Boekhout, T., Akova, M., & Cornely, O. A. (2013) · Cited by 1 · see citing works
Marx, C., & Oberholster, A. (2019) · BIO Web of Conferences · doi:10.1051/bioconf/20191502009 · Cited by 1 · see citing works
Zhang, S. X., & Wiederhold, N. P. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.dmih2-0030-2016 · Cited by 1 · see citing works
Saccharomyces kluyveri fungemia in an infant with severe combined immunodeficiency
Shaikh, S., Shah, I., Rodríguez‐González, M., Castellano‐Martínez, A., Shashidhar, A., Gupta, P., Upadhyay, A., Soni, V. K., Kumar, R., & Luiz, N. (2016) · Indian Pediatrics · doi:10.1007/s13312-016-0944-7
“kluyveri in cases of fungemia, particularly those with reduced susceptibility to azole anti-fungals reinforces the importance of proper mycological examination of these samples [4].”
BackgroundCryptococcosis and other rare invasive yeasts infections
Lee, P., & Goldman, D. L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-64198-2.00036-1
Drew, R. H. (2009) · CRC Press eBooks · doi:10.3109/9780849387869-12
Zhang, S. X., & Wiederhold, N. P. (2016) · ASM Press eBooks · doi:10.1128/9781555819040.ch15
Rowen, J. L. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4044-6.50224-7
- Authors
- Tiballi, R. N., Spiegel, J. E., Zarins, L. T., & Kauffman, C. A.
- Affiliations
- United States Department of Veterans Affairs (US)
- University of Michigan (US)
- Corresponding author
- Kauffman, Carol A.
- Venue
- Diagnostic Microbiology and Infectious Disease
- Publisher
- Elsevier BV
- Published
- 1995-12
- Volume
- 23
- Issue
- 4
- Pages
- 135-140
- ISSN
- 0732-8893 (ISSN-L)
- OpenAlex
- W2032508309
- Cited by
- 31
- References
- 27
- Citations by year
- 2023: 1 · 2020: 2 · 2019: 2 · 2017: 1 · 2016: 3 · 2015: 1 · 2014: 1 · 2013: 2 · 2012: 1
- FWCI
- 1.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diagnostic Microbiology and Infectious Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Yeasts and Rust Fungi Studies
- Keywords
- Saccharomyces cerevisiae, antifungal susceptibility, minimum inhibitory concentration, amphotericin B, 5-fluorocytosine, itraconazole, fluconazole, broth macrodilution, extracorporeal membrane oxygenation, peritonitis, perforated bowel, antifungal therapy
- MeSH terms
- Amphotericin B, Antifungal Agents, Colorimetry, Female, Flucytosine, Humans, Infant, Male, Microbial Sensitivity Tests, Middle Aged, Mycoses, Saccharomyces cerevisiae, Fluconazole, Fatal Outcome, Itraconazole
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
